Goldman Sachs Group Inc Replimune Group, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Replimune Group, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 619,512 shares of REPL stock, worth $7.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
619,512
Previous 666,077 6.99%
Holding current value
$7.74 Million
Previous $5.99 Million 13.26%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$8.09 - $11.23 $376,710 - $522,924
-46,565 Reduced 6.99%
619,512 $6.79 Million
Q2 2024

Aug 13, 2024
BUY
$5.01 - $9.46 $765,212 - $1.44 Million
152,737 Added 29.75%
666,077 $5.99 Million
Q1 2024

May 15, 2024
SELL
$6.87 - $9.31 $11.9 Million - $16.1 Million
-1,725,543 Reduced 77.07%
513,340 $4.19 Million
Q4 2023

Feb 13, 2024
BUY
$6.75 - $16.18 $11.3 Million - $27.2 Million
1,679,553 Added 300.28%
2,238,883 $18.9 Million
Q3 2023

May 14, 2024
SELL
$15.96 - $22.18 $26.8 Million - $37.3 Million
-1,679,553 Reduced 75.02%
559,330 $9.57 Million
Q3 2023

Nov 14, 2023
SELL
$15.96 - $22.18 $852,950 - $1.19 Million
-53,443 Reduced 8.72%
559,330 $9.57 Million
Q2 2023

May 14, 2024
SELL
$15.65 - $24.1 $491,785 - $757,318
-31,424 Reduced 4.88%
612,773 $14.2 Million
Q2 2023

Aug 14, 2023
SELL
$15.65 - $24.1 $491,785 - $757,318
-31,424 Reduced 4.88%
612,773 $14.2 Million
Q1 2023

May 14, 2024
BUY
$17.48 - $29.09 $8.64 Million - $14.4 Million
494,009 Added 328.93%
644,197 $11.4 Million
Q1 2023

May 11, 2023
BUY
$17.48 - $29.09 $8.64 Million - $14.4 Million
494,009 Added 328.93%
644,197 $11.4 Million
Q4 2022

May 14, 2024
SELL
$17.09 - $27.91 $594,526 - $970,933
-34,788 Reduced 18.81%
150,188 $4.09 Million
Q4 2022

Feb 13, 2023
SELL
$17.09 - $27.91 $594,526 - $970,933
-34,788 Reduced 18.81%
150,188 $4.09 Million
Q3 2022

May 14, 2024
SELL
$15.6 - $21.15 $635,294 - $861,312
-40,724 Reduced 18.04%
184,976 $3.2 Million
Q3 2022

Nov 10, 2022
SELL
$15.6 - $21.15 $635,294 - $861,312
-40,724 Reduced 18.04%
184,976 $3.19 Million
Q2 2022

May 14, 2024
SELL
$13.32 - $19.98 $26.8 Million - $40.2 Million
-2,013,183 Reduced 89.92%
225,700 $3.95 Million
Q2 2022

Aug 15, 2022
BUY
$13.32 - $19.98 $1.12 Million - $1.68 Million
84,123 Added 59.42%
225,700 $3.95 Million
Q1 2022

May 16, 2022
BUY
$15.24 - $29.75 $553,608 - $1.08 Million
36,326 Added 34.51%
141,577 $2.4 Million
Q4 2021

Feb 14, 2022
SELL
$25.43 - $34.25 $3.45 Million - $4.65 Million
-135,699 Reduced 56.32%
105,251 $2.85 Million
Q3 2021

Nov 10, 2021
BUY
$28.98 - $39.54 $6.98 Million - $9.53 Million
240,950 New
240,950 $7.14 Million

Others Institutions Holding REPL

# of Institutions
149
Shares Held
68M
Call Options Held
52.3K
Put Options Held
80.3K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $616M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email